Who
Marc D. Kozin
Director
Company insider
Files Form 4 as: Director, UFP Technologies; Director, Chimerix; Director, Dicerna Pharmaceuticals; Director, Isleworth Healthcare Acquisition; Director, Endocyte; Director, Tempest Therapeutics; Director, Decoy Therapeutics; Director and Other, Dyax.
In numbers
- Trades disclosed
- 189
- Buys
- 7
- Sells
- 6
- Bought
- $369K
- Sold
- $5.4M
- Companies
- 8
- Companies where not an officer
- 8
- First trade
- 8 Jun 2006
- Last trade
- 25 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 27 Aug 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Sold | $1.1M3,650 at $303.97 | filing |
| 25 Aug 2026filed 27 Aug 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Sold | $1.0M3,350 at $305.07 | filing |
| 25 Aug 2026filed 27 Aug 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Sold | $1.1M3,650 at $303.97 | filing |
| 25 Aug 2026filed 27 Aug 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Sold | $1.0M3,350 at $305.07 | filing |
| 4 Jun 2026filed 8 Jun 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —802 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —802 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —625 at $0.00 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —100,000 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Chimerixoption or derivative | SEC FORM 4 Code D | —60,000 | filing |
| 6 Sep 2024filed 3 Oct 2024 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code G | —1,500 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Chimerixoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | UFPT UFP Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —493 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —230 at $0.00 | filing |
| 20 Mar 2024filed 21 Mar 2024 | Chimerixoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Jun 2023filed 8 Jun 2023 | UFPT UFP Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —703 at $0.00 | filing |
| 7 Jun 2023filed 8 Jun 2023 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —298 at $0.00 | filing |
| 10 Mar 2023filed 10 Mar 2023 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | UFPT UFP Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,646 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | UFPT UFP TechnologiesMedical Devices | SEC FORM 4 Code A | —647 at $0.00 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,333 | filing |
News
No headline names them, or the companies they trade most, lately.